Pharma news
Pharma
The UK pharmaceutical company filed three lawsuits against Sun Pharma | Sun’s abbreviated new drug application for generic versions of diabetes medications sparks fightback. 7 December 2023
Pharma
USPTO director remanded case back to PTAB after it denied post-grant review of Spruce patents | Judges determined likelihood of claims being unpatentable due to prior art and lack of written description. 5 December 2023
Pharma
Rival drugmakers have dropped lawsuit following invalidation of Teva patents in September | Move comes after judge overturned jury verdict handing $176.5m to Teva. 28 November 2023
Pharma
Judge encourages lawyers and public to make their voices heard over transparency concerns | Awkward access to public hearings ‘causing problems’ says Regeneron counsel | Plea for public virtual hearings as judge notes that requests have been ‘coming in by the dozen’ | Panellists discuss at LSPN Europe. 23 November 2023
Pharma
The European Patent Office hands a win to BioNTech and Pfizer in coronavirus vaccine dispute | US biotech plans to appeal decision affecting mRNA patent. 23 November 2023
Pharma
Big pharma company relies on procedural arguments to fend off a complaint alleging that it engaged in excessive pricing | Feud centres on one of the most successful blockbuster drugs of all time. 16 November 2023
Pharma
Commission targets big pharma companies over ‘improper listings’ | Agency argues that alleged inaccuracies may delay lower-cost generic drug competition, stall drug development, and stifle innovation. 9 November 2023
Pharma
Genomics company’s in-house attorney removed from case over links with patent infringement case | Court denied plaintiff’s motion to disqualify entire legal team. 7 November 2023
Pharma
US Court of Appeals dismisses appeal due to a ‘lack of jurisdiction’ | Dispute against Jiangsu Hengrui Pharmaceuticals began as a patent suit but the discovery process prompted trade secret claims. 31 October 2023
Pharma
Swiss multinational says competitor has been “uncooperative” in investigation into whether former Novartis employee took trade secrets |Novartis files complaint for discovery, asking for permission to issue subpoena. 26 October 2023